Literature DB >> 26071870

Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation.

Kazushige Sato1, Yuichi Miura, Yuhji Marui, Kiho Tanaka, Shinji Tomikawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26071870     DOI： 10.1007/s11255-015-1026-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  9 in total

1.  Mutism and persistent dysarthria due to tacrolimus-based immunosuppression following allogeneic liver transplantation.

Authors:  David Vearrier; Serge-Emile Simpson; Michael I Greenberg
Journal:  Am J Ther       Date:  2011-11       Impact factor: 2.688

2.  Expressive dysphasia possibly related to FK506 in two liver transplant recipients.

Authors:  J Reyes; T Gayowski; J Fung; S Todo; M Alessiani; T E Starzl
Journal:  Transplantation       Date:  1990-12       Impact factor: 4.939

3.  Loss of speech after living-related donor liver transplantation: detection of the lesion by diffusion tensor image.

Authors:  K S Jeng; S H Chu; C C Huang; C K Lin; C C Lin; K H Chen
Journal:  Transplant Proc       Date:  2014-04       Impact factor: 1.066

4.  Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity.

Authors:  I Bilbao; C Dopazo; L Castells; J Lazaro; M Caralt; G Sapisochin; R Charco
Journal:  Transplant Proc       Date:  2014-11       Impact factor: 1.066

5.  Tacrolimus-associated mutism after orthotopic liver transplantation.

Authors:  D J Bronster; A Gurkan; M S Buchsbaum; S Emre
Journal:  Transplantation       Date:  2000-09-27       Impact factor: 4.939

6.  Reversible acute encephalopathy with mutism, induced by calcineurin inhibitors after renal transplantation.

Authors:  Katia Toledo Perdomo; María-Dolores Navarro Cabello; María-José Pérez Sáez; Manuel José Ramos Pérez; Maria Luisa Agüera Morales; Pedro Aljama García
Journal:  J Nephrol       Date:  2012 Sep-Oct       Impact factor: 3.902

7.  Dysarthria and apraxia of speech associated with FK-506 (tacrolimus).

Authors:  B F Boeve; D W Kimmel; A E Aronson; P C de Groen
Journal:  Mayo Clin Proc       Date:  1996-10       Impact factor: 7.616

8.  Tacrolimus (FK506)-induced mutism after liver transplant.

Authors:  Deborah K Sokol; Jean P Molleston; Ronald S Filo; Joseph Van Valer; Mary Edwards-Brown
Journal:  Pediatr Neurol       Date:  2003-02       Impact factor: 3.372

9.  Akinetic mutism induced by tacrolimus.

Authors:  Fernando Sierra-Hidalgo; Antonio Martínez-Salio; Sara Moreno-García; Eduardo de Pablo-Fernández; Elisa Correas-Callero; Juan Ruiz-Morales
Journal:  Clin Neuropharmacol       Date:  2009 Sep-Oct       Impact factor: 1.592
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.